ZIMMER BIOMET HOLDINGS, INC.
ZBHHealthcarezimmer.com
Latest available resultsSeptember 30, 2026Quarter · 10-Q filed Nov 4, 2026
Next reportFebruary 8, 2027after close · forecast 2.518 $/share
Revenue
$2.06B
▲ +3.1% vs prior year YoY
Net income
$191.60M
▼ -17.0% vs prior year YoY
EPS
1.00$
▼ -13.8% vs prior year YoY
Net margin
9.3%
▼ -2.2 pp vs prior year YoY
Revenue▲ +3.1%
Margins (% of revenue)GrossOperatingNet
Net income▼ -17.0%
EPS▼ -13.8%
Financial statements
View 10-Q filed November 4, 2026 on SEC ↗| Metric | Dec 2024* | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025* | Mar 2026 | Jun 2026 | Sep 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $2.02B | $1.91B | $2.08B | $2.00B | $2.24B | $2.09B | $2.18B | $2.06B | ▲ +3.1% |
| Gross profit | $1.44B | $1.36B | $1.49B | $1.44B | $1.45B | $1.51B | $1.54B | $1.47B | ▲ +1.8% |
| Operating income | $389.00M | $292.30M | $300.00M | $351.30M | $154.50M | $373.20M | $326.10M | $307.60M | ▼ -12.4% |
| Net income | $239.50M | $182.00M | $152.80M | $230.90M | $139.40M | $238.10M | $198.30M | $191.60M | ▼ -17.0% |
| R&D | — | — | — | — | — | — | — | — | — |
| EPS (diluted) | — | 0.91 $ | 0.77 $ | 1.16 $ | — | 1.22 $ | 1.03 $ | 1.00 $ | ▼ -13.8% |
| Margins (% of revenue) | |||||||||
| Gross | 71.0 % | 71.2 % | 71.5 % | 72.1 % | 64.7 % | 72.4 % | 70.8 % | 71.2 % | ▼ -0.9 pt |
| Operating | 19.2 % | 15.3 % | 14.4 % | 17.6 % | 6.9 % | 17.9 % | 15.0 % | 14.9 % | ▼ -2.6 pt |
| Net | 11.8 % | 9.5 % | 7.4 % | 11.5 % | 6.2 % | 11.4 % | 9.1 % | 9.3 % | ▼ -2.2 pt |
| Balance sheet | |||||||||
| Assets | $21.37B | $22.18B | $22.87B | $23.49B | $23.09B | $22.72B | $22.80B | $23.54B | ▲ +0.2% |
| Liabilities | $8.89B | $9.78B | $10.33B | $10.72B | $10.39B | $10.04B | $10.17B | $10.81B | ▲ +0.8% |
| Equity | $12.48B | $12.40B | $12.53B | $12.77B | $12.71B | $12.68B | $12.63B | $12.73B | ▼ -0.3% |
| Cash | $525.50M | $1.38B | $556.90M | $1.29B | $591.90M | $424.20M | $410.00M | $399.90M | ▼ -69.1% |
| Capital | |||||||||
| Shares outstanding | 199.06M | 197.85M | 198.10M | 198.18M | 195.65M | 193.46M | 190.74M | 189.25M | ▼ -4.5% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.